These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6285809)

  • 21. [Clinical and pharmacokinetic study on cefodizime, a new cephalosporin antibiotic, in the pediatric infections].
    Arimasu O; Meguro H; Hiruma F; Sugie N; Abe T
    Jpn J Antibiot; 1989 Jun; 42(6):1293-305. PubMed ID: 2795854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ceftriaxone administered once or twice a day for treatment of bacterial infections of childhood.
    Higham M; Cunningham FM; Teele DW
    Pediatr Infect Dis; 1985; 4(1):22-6. PubMed ID: 3969362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of cefotaxime, a beta-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms.
    Francke EL; Neu HC
    Am J Med; 1981 Sep; 71(3):435-42. PubMed ID: 6269426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic and microbial susceptibility studies of ceftriaxone.
    Baumgartner JD; Glauser MP
    Eur J Clin Microbiol; 1983 Oct; 2(5):501-4. PubMed ID: 6315426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceftriaxone monotherapy for severe bacteremic infections. Spanish Ceftriaxone Study Group.
    Soriano E; Gatell JM; Aguado JM; Aguirre JM; Arazo P; Arribas JL; Barros C; Cartón JA; Gurgui M; Jiménez E
    Chemotherapy; 1989; 35 Suppl 2():27-32. PubMed ID: 2612237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.
    Bradsher RW; Snow RM
    Am J Med; 1984 Oct; 77(4C):63-7. PubMed ID: 6093522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceftriaxone for the treatment of serious infections.
    Steele RW; Bradsher RW
    Am J Dis Child; 1983 Nov; 137(11):1044-7. PubMed ID: 6314805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Once-daily ceftriaxone therapy for serious bacterial infections in children.
    Congeni BL; Chonmaitree T; Rakusan TA; Box QT
    Antimicrob Agents Chemother; 1985 Feb; 27(2):181-3. PubMed ID: 3985602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Richards DM; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Jun; 27(6):469-527. PubMed ID: 6329638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical applications of a new parenteral antibiotic in the treatment of severe bacterial infections.
    Holloway WJ; Palmer D
    Am J Med; 1996 Jun; 100(6A):52S-59S. PubMed ID: 8678098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Third-generation and investigational cephalosporins: II. Microbiologic review and clinical summaries.
    Garzone P; Lyon J; Yu VL
    Drug Intell Clin Pharm; 1983 Sep; 17(9):615-22. PubMed ID: 6311502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of cefodizime (HR-221).
    Ahonkhai VI; Cherubin CE; Shulman MA
    Antimicrob Agents Chemother; 1982 Oct; 22(4):715-8. PubMed ID: 6295264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of ceftriaxone (R013-9904) in the treatment of septicemia caused by gram-negative bacilli].
    Naessens A; Pierard D; Roels P; Lauwers S
    Pathol Biol (Paris); 1983 May; 31(5):362-5. PubMed ID: 6312398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.
    Neu HC; Meropol NJ; Fu KP
    Antimicrob Agents Chemother; 1981 Mar; 19(3):414-23. PubMed ID: 6972729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trials of cefotaxime for the treatment of bacterial infections of the lower respiratory tract.
    Perkins RL
    Rev Infect Dis; 1982; 4 Suppl():S421-31. PubMed ID: 6294794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation and perspectives of a new cephalosporin: ceftriaxone].
    Auvergnat JC; Armengaud M
    Rev Med Interne; 1985 Mar; 6(2):187-92. PubMed ID: 3839091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftizoxime: a beta-lactamase-stable, broad-spectrum cephalosporin. Pharmacokinetics, adverse effects and clinical use.
    Neu HC
    Pharmacotherapy; 1984; 4(2):47-60. PubMed ID: 6326062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftriaxone: pharmacokinetics and effect on the intestinal microflora in patients with acute bacterial infections.
    Nilsson-Ehle I; Nord CE; Ursing B
    Scand J Infect Dis; 1985; 17(1):77-82. PubMed ID: 3992209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefmenoxime therapy of serious bacterial infections.
    Gombert ME; Glasser LA; Eng RH
    Antimicrob Agents Chemother; 1984 Apr; 25(4):510-2. PubMed ID: 6329082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of cephalosporins in the treatment of bacterial meningitis in adults. Overview with special emphasis on ceftazidime.
    Norrby SR
    Am J Med; 1985 Aug; 79(2A):56-61. PubMed ID: 3895919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.